In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.

Similar Items

• In Vitro and In Vivo Efficacy of the Triazole TAK-187 against Cryptococcus neoformans
  od: Schell, Wiley A., i dr.
  Izdano: (1998)
• In Vitro and In Vivo Efficacies of the New Triazole Albaconazole against Cryptococcus neoformans
  od: Miller, J. L., i dr.
  Izdano: (2004)
• In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
  od: Sugar, A M, i dr.
  Izdano: (1996)
• In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts.
  od: Galgiani, J N, i dr.
  Izdano: (1997)
• In Vitro Activities of Posaconazole (Sch 56592) Compared with Those of Itraconazole and Fluconazole against 3,685 Clinical Isolates of Candida spp. and Cryptococcus neoformans
  od: Pfaller, M. A., i dr.
  Izdano: (2001)